Jane Henderson, Director at Akero Therapeutics, Inc. (AKRO), sold 80,000 shares at $53.79 ($4.3M) on 2023-06-16, disclosed to the SEC on 2023-06-21.
Open-market sale of $4.3M AKRO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.79 | 17,502 | $941K | 21.7% |
| 2 | $53.79 | 17,502 | $941K | 21.7% |
| 3 | $54.46 | 22,498 | $1.2M | 28.3% |
| 4 | $54.46 | 22,498 | $1.2M | 28.3% |
| Total | $54.17 avg | 80,000 | $4.3M | 100% |
| Filing → |
| APGE | SELL | 2026-04-03 | $170K | — | Filing → |
| APGE | SELL | 2026-03-27 | $170K | — | Filing → |
| APGE | SELL | 2026-03-04 | $140K | — | Filing → |